Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lynne Powell currently holds 12,500 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lynne Powell has been a net seller of BCRX stock. They have purchased $0 and sold $538.7K worth of shares.
Lynne Powell's most recent insider trade was on Jun 5, 2024, when they sold 12,500 shares at $0.00 per share.
Lynne Powell serves as Executive at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 42 insider transactions totaling $538.7K over their tenure at the company.
Lynne Powell holds the position of Executive at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Lynne Powell has shown a selling trading pattern, with $0 in total purchases and $538.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lynne Powell was on Nov 21, 2018, when they sold $108.7K worth of BCRX shares. This transaction involved 12,000 shares at $9.06 per share.
Lynne Powell currently owns 12,500 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lynne Powell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lynne Powell has 42 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for Lynne Powell and 40,000+ other insiders.